2007 Annual Report - College of Pharmacy - The Ohio State University
2007 Annual Report - College of Pharmacy - The Ohio State University
2007 Annual Report - College of Pharmacy - The Ohio State University
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
NIH Grants Awarded FY2006<br />
NIH, Principal Investigator<br />
Name Institute Project Title FY06 Award<br />
Au, Jessie L.-S. National Cancer Institute FGF: a mechanism <strong>of</strong> acquired $245,219<br />
multidrug resistance<br />
Brueggemeier, Robert W. National Cancer Institute Estrogen biotransformations and breast $270,783<br />
cancer etiology<br />
Chan, Kenneth K National Cancer Institute Preclinical pharmacological study <strong>of</strong> $436,610<br />
antitumor and other agnts<br />
Chen, Ching-Shih National Cancer Institute Novel Celecoxib Derivatives as $134,550<br />
Chemopreventive Agents<br />
Chen, Ching-Shih National Cancer Institute Targeting Akt and Bcl-2 in prostate cancer $288,324<br />
prevention<br />
Curley, Robert W. National Cancer Institute Analog studies <strong>of</strong> 4-HPR and its glucuronide $268,719<br />
Dalton, James T. Nat. Inst. Diabetes, Digestive, Pharmacology <strong>of</strong> nonsteroidal androgen $326,318<br />
Kidney Dis<br />
receptor ligands<br />
Knoell, Daren L. National Heart lung Blood Cytolytic attack against lung parenchyma $126,942<br />
in emphysema<br />
Kvaratskhelia, M. Nat. Inst. Allergy & Infect. Dis. Structural studies <strong>of</strong> HIV-1 integration $287,417<br />
Kvaratskhelia, M. Nat. Inst. Allergy & Infect. Dis. HIV-1 gag structure as a therapeutic target $149,500<br />
Lee, Robert J. National Cancer Institute Targeted liposomal doxorubicin delivery $296,904<br />
to leukemia<br />
Pawlus, Alison D. NIH NCCAM Effect <strong>of</strong> Noni on Diabetic Cardiovascular $58,036<br />
Disease<br />
Werbovetz, Karl A. Nat. Inst. Allergy & Infect. Dis. Simple, Selective Antimitotic Antiparasitic $307,686<br />
Agents<br />
Wientjes, M. Guillaume National Cancer Institute Enhanced Chemosensitivity <strong>of</strong> Pancreatic $265,742<br />
Cancer<br />
Wientjes, M. Guillaume National Cancer Institute Tumor priming to promote nanoparticle $156,936<br />
gene delivery<br />
NIH via subprojects and subcontracts<br />
Name Institute Project Title FY06 Award<br />
Dalton, James T. National Cancer Institute Cancer Center Core grant $81,029<br />
Dalton, James T. NIH via <strong>University</strong> <strong>of</strong> Novel irreversible SARMs for prostate $126,762<br />
Tennessee<br />
cancer<br />
Tjarks, Werner NIH via Barth subproject Molecular targeting <strong>of</strong> EGFR for the $32,048<br />
treatment <strong>of</strong> gliomas<br />
44
Change language